Literature DB >> 26526945

Magnetic Resonance (MR) Metabolic Imaging in Glioma.

Myriam M Chaumeil1, Janine M Lupo1, Sabrina M Ronen1,2.   

Abstract

This review is focused on describing the use of magnetic resonance (MR) spectroscopy for metabolic imaging of brain tumors. We will first review the MR metabolic imaging findings generated from preclinical models, focusing primarily on in vivo studies, and will then describe the use of metabolic imaging in the clinical setting. We will address relatively well-established (1) H MRS approaches, as well as (31) P MRS, (13) C MRS and emerging hyperpolarized (13) C MRS methodologies, and will describe the use of metabolic imaging for understanding the basic biology of glioma as well as for improving the characterization and monitoring of brain tumors in the clinic.
© 2015 International Society of Neuropathology.

Entities:  

Keywords:  brain tumors; glioma; magnetic resonance imaging; metabolic imaging

Mesh:

Year:  2015        PMID: 26526945     DOI: 10.1111/bpa.12310

Source DB:  PubMed          Journal:  Brain Pathol        ISSN: 1015-6305            Impact factor:   6.508


  15 in total

1.  HDAC inhibition in glioblastoma monitored by hyperpolarized 13 C MRSI.

Authors:  Marina Radoul; Chloé Najac; Pavithra Viswanath; Joydeep Mukherjee; Mark Kelly; Anne Marie Gillespie; Myriam M Chaumeil; Pia Eriksson; Romelyn Delos Santos; Russell O Pieper; Sabrina M Ronen
Journal:  NMR Biomed       Date:  2018-12-18       Impact factor: 4.044

Review 2.  MR Molecular Imaging of Brain Cancer Metabolism Using Hyperpolarized 13C Magnetic Resonance Spectroscopy.

Authors:  Chloé Najac; Sabrina M Ronen
Journal:  Top Magn Reson Imaging       Date:  2016-10

3.  Metabolic Reprogramming in Brain Cancer: A Coordinated Effort.

Authors:  Sriram Venneti; Paul S Mischel
Journal:  Brain Pathol       Date:  2015-11       Impact factor: 6.508

4.  Elevated fibroblast growth factor-inducible 14 expression transforms proneural-like gliomas into more aggressive and lethal brain cancer.

Authors:  Nina P Connolly; Rebeca Galisteo; Su Xu; Eli E Bar; Sen Peng; Nhan L Tran; Heather M Ames; Anthony J Kim; Graeme F Woodworth; Jeffrey A Winkles
Journal:  Glia       Date:  2021-05-15       Impact factor: 7.452

5.  Hyperpolarized (13)C MR imaging detects no lactate production in mutant IDH1 gliomas: Implications for diagnosis and response monitoring.

Authors:  Myriam M Chaumeil; Marina Radoul; Chloé Najac; Pia Eriksson; Pavithra Viswanath; Michael D Blough; Charles Chesnelong; H Artee Luchman; J Gregory Cairncross; Sabrina M Ronen
Journal:  Neuroimage Clin       Date:  2016-06-23       Impact factor: 4.881

6.  Magnetic Resonance Spectroscopy and Single-Photon Emission Computed Tomography in the Evaluation of Cerebral Tumors: A Case Report.

Authors:  Ioannis Siasios; Varvara Valotassiou; Eftychia Kapsalaki; Ioannis Tsougos; Panagiotis Georgoulias; Aggeliki Fotiadou; Maria Ioannou; Georgios Koukoulis; Vassilios Dimopoulos; Kostas Fountas
Journal:  J Clin Med Res       Date:  2016-11-24

Review 7.  Monitoring the Neuroinflammatory Response Following Acute Brain Injury.

Authors:  Eric Peter Thelin; Tamara Tajsic; Frederick Adam Zeiler; David K Menon; Peter J A Hutchinson; Keri L H Carpenter; Maria Cristina Morganti-Kossmann; Adel Helmy
Journal:  Front Neurol       Date:  2017-07-20       Impact factor: 4.003

8.  In silico gene expression analysis reveals glycolysis and acetate anaplerosis in IDH1 wild-type glioma and lactate and glutamate anaplerosis in IDH1-mutated glioma.

Authors:  Mohammed Khurshed; Remco J Molenaar; Krissie Lenting; William P Leenders; Cornelis J F van Noorden
Journal:  Oncotarget       Date:  2017-07-25

9.  Mapping of Metabolic Heterogeneity of Glioma Using MR-Spectroscopy.

Authors:  Pamela Franco; Irene Huebschle; Carl Philipp Simon-Gabriel; Karam Dacca; Oliver Schnell; Juergen Beck; Hansjoerg Mast; Horst Urbach; Urs Wuertemberger; Marco Prinz; Jonas A Hosp; Daniel Delev; Irina Mader; Dieter Henrik Heiland
Journal:  Cancers (Basel)       Date:  2021-05-17       Impact factor: 6.639

10.  Mutant IDH1 expression is associated with down-regulation of monocarboxylate transporters.

Authors:  Pavithra Viswanath; Chloe Najac; Jose L Izquierdo-Garcia; Aleksandr Pankov; Chibo Hong; Pia Eriksson; Joseph F Costello; Russell O Pieper; Sabrina M Ronen
Journal:  Oncotarget       Date:  2016-06-07
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.